USD 2.17 billion
Interventional Oncology Market Size, Share, Growth Analysis, By Product (Embolization Devices, Ablation Devices), By Cancer Type (Liver Cancer, Kidney Cancer), By Procedure (TARE/SIRT, TACE), By End-User (Hospitals, Ambulatory Surgery Centers), By Region - Industry Forecast 2025-2032
Report ID:
SQMIG35G2238 |
Region:
Global |
Published Date: September, 2024
Pages:
242
|Tables:
147
|Figures:
78
Interventional Oncology Market Insights
Interventional Oncology Market size was valued at USD 2.31 Billion in 2023 and is poised to grow from USD 2.47 Billion in 2024 to USD 4.19 Billion by 2032, growing at a CAGR of 6.8% during the forecast period (2025-2032).
Treatment and diagnosis of cancer using minimally invasive techniques and image guidance are included in interventional oncology procedures. Equipment including computed tomography, ultrasonography, magnetic resonance imaging, and x-rays are used in the process to provide guidance. Image guidance is used for planning and executing interventional oncology operations, which target and destroy cancer. These treatments are performed under the supervision of CT/USG or in a cutting-edge oncology cath lab. Targeting tumors located in distant areas of the body is made possible using guide accessories and instruments, such as intravascular catheters, biopsy needles, ablation electrodes, and guidewires.
Together with radiation, surgery, and medicine oncology, the quickly expanding discipline of interventional oncology has emerged as a key component of cancer care. To diagnose, treat, and/or alleviate cancer symptoms, the interventional oncology program employs focused, minimally invasive treatments carried out with the aid of image guidance. To minimize the necessity for invasive operations, cancer patients are referred to interventional oncologists for the integration of minimally invasive treatment. As part of their diagnostic practice, interventional oncologists can also execute endoscopies and colonoscopies. Cancers such as liver, kidney, lung, bone, prostate, breast, and pancreatic cancers, as well as those that have metastasized, are treated using interventional oncology.
US Interventional Oncology Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
Hospitals
Fastest Growth
Hospitals
Growth Rate
6.8% CAGR
Global Interventional Oncology Market ($ Bn)
Country Share by North America (%)
To get more reports on the above market click here to Buy The Report
Interventional Oncology Market Segmental Analysis
Global Interventional Oncology Market is segmented on the basis of product, cancer type, procedure, end user, and region. By product, the market is segmented into Embolization Devices, Ablation Devices, and Support Devices. By Cancer Type, the market is segmented into Liver Cancer, Kidney Cancer, Breast Cancer, Lung Cancer, Bone Cancer, Prostate Cancer, and Other Cancers. By procedure, the market is segmented into Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy (TARE/SIRT), Transcatheter Arterial Chemoembolization (TACE), Thermal Tumor Ablation, and Transcatheter Arterial Embolization/Bland Embolization (TAE). By end-user, the market is segmented into hospitals, ambulatory surgery centers, and research & academic institutes. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Interventional Oncology Market Analysis by Product
As per categorization by product, the market is classified as embolization devices, ablation devices and support devices. Among these, embolization devices earned the largest share and continue to dominate the market. Embolization devices are gaining traction in the global interventional oncology market due to advancements in technology, such as biocompatible materials and enhanced imaging techniques. Their dominance stems from their ability to effectively target tumors, minimize collateral damage, and improve patient outcomes, driving increased adoption in minimally invasive cancer treatments.
Support devices are poised to be the fastest-growing segment in the global interventional oncology market due to their crucial role in enhancing procedural efficiency and patient safety. Innovations such as advanced guidewires and hemostatic devices streamline complex interventions, reduce complications, and improve recovery times. Furthermore, the rising prevalence of cancer and the increasing demand for minimally invasive procedures are propelling the adoption of these support devices, making them essential tools in modern oncology treatments and interventions.
Interventional Oncology Market Analysis by End Users
Hospitals are the primary end-users in the global interventional oncology market, leveraging innovations like advanced imaging and minimally invasive techniques. Their dominance is attributed to the increasing patient volume, enhanced treatment efficacy, and the integration of multidisciplinary approaches, positioning hospitals as key facilitators in delivering comprehensive cancer care solutions.
Ambulatory surgery centers (ASCs) are set to become the fastest-growing segment in the global interventional oncology market due to their ability to provide cost-effective, outpatient care for patients requiring minimally invasive procedures. With shorter recovery times, ASCs enhance patient satisfaction and operational efficiency. The increasing focus on reducing healthcare costs and the growing demand for same-day discharge options are driving the shift toward ASCs. Additionally, advancements in technology and procedural techniques further position ASCs as attractive alternatives to traditional hospital settings.
Global Interventional Oncology Market By Product (%)
To get detailed analysis on other segments, Request For Free Sample Report
Interventional Oncology Market Regional Insights
North America dominates the global interventional oncology market share due to a combination of advanced healthcare infrastructure, high levels of investment in research and development, and a strong presence of key market players. The region benefits from a growing number of cancer cases, which drives demand for innovative treatment options. Additionally, robust reimbursement policies and the adoption of minimally invasive techniques have contributed to increased procedure volumes. The presence of leading hospitals and specialized oncology centers facilitates cutting-edge treatments, further enhancing patient access. Furthermore, ongoing collaborations between healthcare providers and technology developers are accelerating advancements, solidifying North America's leadership in interventional oncology.
Asia Pacific is the fastest-growing market for interventional oncology, driven by rising cancer incidence rates, increasing healthcare expenditure, and a growing awareness of advanced treatment options. Rapid urbanization and an aging population are contributing to a higher demand for effective oncology solutions. Additionally, the region is witnessing significant improvements in healthcare infrastructure, particularly in countries like China and India, which are investing heavily in modernizing hospitals and medical facilities. The proliferation of training programs for healthcare professionals and collaborations with global medical technology firms further enhance capabilities and access to innovative treatments, positioning Asia Pacific as a dynamic player in the interventional oncology landscape.
Global Interventional Oncology Market By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Interventional Oncology Market Dynamics
Interventional Oncology Market Driver
Rising Incidence of Cancer
- The increasing prevalence of cancer globally is a significant driver of the interventional oncology market. With a growing aging population and lifestyle-related risk factors, the demand for effective cancer treatment options is escalating. This trend prompts healthcare providers to adopt innovative interventional procedures, enhancing patient outcomes and survival rates.
Technological Advancements in Imaging Techniques
- Technological advancements in imaging and minimally invasive techniques are revolutionizing interventional oncology. Innovations such as enhanced imaging modalities and precision-targeted therapies allow for better tumor localization and treatment efficacy. These advancements not only improve procedural outcomes but also increase patient safety, leading to higher adoption rates of interventional oncology procedures among healthcare providers.
Interventional Oncology Market Restraints
Limited Awareness and Training
- Limited awareness and training regarding interventional oncology techniques among healthcare professionals can restrict market growth. Many practitioners may not be familiar with the latest innovations or procedures, leading to underutilization. Additionally, the need for specialized training can slow the adoption of new technologies in various healthcare settings.
Competing Treatment Options
- The presence of alternative treatment modalities, such as traditional chemotherapy and radiation therapy, can restrain the interventional oncology market. Some patients and healthcare providers may prefer these established methods due to familiarity and perceived effectiveness. This competition can slow the adoption of interventional techniques, impacting market growth and innovation.
Request Free Customization of this report to help us to meet your business objectives.
Interventional Oncology Market Competitive Landscape
The competitive landscape of the global interventional oncology market is characterized by a mix of established players and emerging companies focusing on innovation and technological advancements. Key players include Medtronic, Boston Scientific, Siemens Healthineers, and Terumo Corporation, all of which are actively developing advanced devices and therapies. These companies emphasize collaborations and strategic partnerships to enhance their product portfolios and improve patient outcomes, driving competition and fostering continuous improvement in interventional oncology solutions worldwide.
Interventional Oncology Market Top Player's Company Profiles
- Boston Scientific Corporation (US)
- Medtronic plc (Ireland)
- Johnson & Johnson (US)
- Terumo Corporation (Japan)
- Merit Medical Systems, Inc. (US)
- Teleflex, Inc. (US)
- AngioDynamics, Inc. (US)
- Becton, Dickinson and Company (US)
- Healthtronics, Inc. (US)
- Trod Medical (US)
- Sanarus Technologies, Inc. (US)
- Imbiotechnologies Ltd. (UK)
- Medwaves, Inc. (US)
- IceCure Medical (Israel)
- Cook Medical (US)
- Profound Medical Corp. (Canada)
- Sirtex Medical (Australia)
- Baylis Medical Company, Inc. (Canada)
- Accuray (US)
- Alpinion Medical Systems (South Korea)
Interventional Oncology Market Recent Development
- In September 2023, Cook Medical announced the launch of its latest embolization device, designed for treating tumors more effectively with improved precision. This innovative device utilizes advanced imaging technology, enabling interventional radiologists to achieve better targeting and reduced complication rates, enhancing patient outcomes in interventional oncology procedures.
- In August 2023, Boston Scientific unveiled its next-generation radiofrequency ablation system for liver tumors. This system integrates advanced imaging techniques and real-time monitoring capabilities, allowing for more accurate treatment delivery. The launch reflects Boston Scientific's commitment to advancing minimally invasive oncology therapies and improving patient experiences during interventional procedures.
- In July 2023, Medtronic announced a significant collaboration with a leading oncology center to evaluate the effectiveness of its novel drug-coated balloons for treating liver cancers. This partnership aims to enhance clinical outcomes by leveraging Medtronic's innovative technologies, focusing on providing safer and more effective interventional oncology treatments for patients globally.
Interventional Oncology Key Market Trends
Growing Adoption of Minimally Invasive Procedures:
- There is a significant trend toward minimally invasive interventional oncology techniques, driven by their ability to reduce recovery times and complications. Patients and healthcare providers increasingly favor these approaches, leading to the development and integration of advanced technologies that enhance precision and effectiveness in cancer treatment.
Rising Demand for Personalized Cancer Treatments:
- The global interventional oncology market is witnessing a shift towards personalized treatment options. As precision medicine gains traction, healthcare providers are increasingly adopting tailored therapies based on individual patient profiles, including tumor characteristics. This trend emphasizes the need for innovative technologies and techniques that can deliver customized interventions effectively.
Interventional Oncology Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, in conclusion, the global interventional oncology market is experiencing significant advancements through the integration of minimally invasive techniques and image guidance in cancer treatment. The rise of innovative technologies, such as embolization and ablation devices, has revolutionized patient care by enhancing precision and outcomes.
Hospitals and ambulatory surgery centers are crucial end-users, facilitating efficient procedures and improving accessibility. Despite challenges like limited awareness and competition from traditional therapies, the market continues to grow, driven by increasing cancer incidences and a demand for personalized treatment options. The future of interventional oncology looks promising, with continuous developments and emerging players shaping the landscape.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 2.17 billion |
| Market size value in 2031 | USD 3.92 billion |
| Growth Rate | 6.8% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Interventional Oncology Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Interventional Oncology Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Interventional Oncology Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Interventional Oncology Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Interventional Oncology Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Interventional Oncology Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
